Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 20:11:1426551.
doi: 10.3389/fnut.2024.1426551. eCollection 2024.

Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility

Affiliations
Review

Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility

Sara Paola Mambrini et al. Front Nutr. .

Abstract

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has emerged as a prevalent health concern, encompassing a wide spectrum of liver-related disorders. Insulin resistance, a key pathophysiological feature of MASLD, can be effectively ameliorated through dietary interventions. The Mediterranean diet, rich in whole grains, fruits, vegetables, legumes, and healthy fats, has shown promising results in improving insulin sensitivity. Several components of the Mediterranean diet, such as monounsaturated fats and polyphenols, exert anti-inflammatory and antioxidant effects, thereby reducing hepatic steatosis and inflammation. Furthermore, this dietary pattern has been associated with a higher likelihood of achieving MASLD remission. In addition to dietary modifications, physical exercise, particularly resistance exercise, plays a crucial role in enhancing metabolic flexibility. Resistance exercise training promotes the utilization of fatty acids as an energy source. It enhances muscle glucose uptake and glycogen storage, thus reducing the burden on the liver to uptake excess blood glucose. Furthermore, resistance exercise stimulates muscle protein synthesis, contributing to an improved muscle-to-fat ratio and overall metabolic health. When implemented synergistically, the Mediterranean diet and resistance exercise can elicit complementary effects in combating MASLD. Combined interventions have demonstrated additive benefits, including greater improvements in insulin resistance, increased metabolic flexibility, and enhanced potential for MASLD remission. This underscores the importance of adopting a multifaceted approach encompassing dietary modifications and regular physical exercise to effectively manage MASLD. This narrative review explores the biological mechanisms of diet and physical exercise in addressing MASLD by targeting insulin resistance and decreased metabolic flexibility.

Keywords: MASLD; Mediterranean diet; insulin resistance; metabolic flexibility; physical exercise; resistance exercise.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor BR-M declared a past co-authorship with the authors SC and SB.

Figures

Figure 1
Figure 1
Summary of the mechanisms by which aerobic exercise and resistance exercise improve insulin sensitivity and metabolic flexibility, respectively [adapted from Hashida et al. (64)].
Figure 2
Figure 2
Effects of insulin resistance in the liver, white adipose tissue, and skeletal muscle.

References

    1. Younossi ZM, Henry L. Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP Rep. (2021) 3:100305. doi: 10.1016/j.jhepr.2021.100305, PMID: - DOI - PMC - PubMed
    1. Colosimo S, Marchesini G. Editorial: should NAFLD be included in the definition of metabolic syndrome? Aliment Pharmacol Ther. (2023) 57:1151–2. doi: 10.1111/apt.17411 - DOI - PubMed
    1. Marjot T, Moolla A, Cobbold JF, Hodson L, Tomlinson JW. Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management. Endocr Rev. (2020) 41:66–117. doi: 10.1210/endrev/bnz009, PMID: - DOI - PubMed
    1. Colosimo S, Ravaioli F, Petroni ML, Brodosi L, Marchignoli F, Barbanti FA, et al. . Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: a real-world data analysis. Liver Int. (2021) 41:731–42. doi: 10.1111/liv.14799, PMID: - DOI - PMC - PubMed
    1. Colosimo S, Tan GD, Petroni ML, Marchesini G, Tomlinson JW. Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent. Nutr Metab Cardiovasc Dis. (2022) 33:640–8. doi: 10.1016/j.numecd.2022.12.010 - DOI - PubMed

LinkOut - more resources